FDA Inspection
Teva Pharmaceuticals USA, IncTeva Pharmaceuticals USA, Inc – FDA Inspection, Dec 16, 2021
Record Details
This FDA Inspection record concerns Teva Pharmaceuticals USA, Inc, with an inspection on December 16, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 16, 2021
- Product Type
- Drugs
View Company Profile
ID · 712adb63-860a-4293-b96c-4733ea68e23f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1160882
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Teva Pharmaceuticals USA, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2025 | Not classified | New Jersey District Office | |
| September 29, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 2, 2010 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 1, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 14, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Pharmaceuticals USA, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.